The R-isomer of albuterol.
The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed)
A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
A small aerosol canister used to release a calibrated amount of medication for inhalation.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
Drugs that selectively bind to and activate beta-adrenergic receptors.

Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD. (1/1)

 (+info)

Levalbuterol is a medication that is used to treat and prevent bronchospasms, or narrowing of the airways in the lungs, in people with respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is a type of short-acting beta-agonist (SABA), which works by relaxing muscles in the airways and increasing the flow of air into the lungs.

Levalbuterol is the active ingredient in the drug Levalbuterol HCl, which is available as an inhalation solution for use with a nebulizer or as a metered-dose inhaler (MDI). It is also available in combination with other medications, such as ipratropium, in products used to treat and prevent bronchospasms.

Levalbuterol is generally considered to be safe and effective when used as directed. However, it can cause side effects, including tremors, nervousness, headache, and rapid heart rate. It is important to follow the instructions for use provided by a healthcare professional and to report any bothersome or persistent side effects to a healthcare provider.

Drug incompatibility refers to a situation where two or more drugs cannot be mixed, combined, or administered together because they will interact in a way that reduces their effectiveness, causes unintended side effects, or even results in harm to the patient. This can occur due to chemical reactions between the drugs, physical interactions (such as precipitation), or pharmacological interactions (such as one drug inhibiting the metabolism of another).

Drug incompatibilities can be identified through various methods, including laboratory testing, literature review, and clinical experience. Healthcare professionals must be aware of potential drug incompatibilities and take steps to avoid them when prescribing or administering medications to patients. This may involve using different administration routes, changing the timing of medication administration, or selecting alternative drugs that are compatible with each other.

Albuterol is a medication that is used to treat bronchospasm, or narrowing of the airways in the lungs, in conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is a short-acting beta-2 agonist, which means it works by relaxing the muscles around the airways, making it easier to breathe. Albuterol is available in several forms, including an inhaler, nebulizer solution, and syrup, and it is typically used as needed to relieve symptoms of bronchospasm. It may also be used before exercise to prevent bronchospasm caused by physical activity.

The medical definition of Albuterol is: "A short-acting beta-2 adrenergic agonist used to treat bronchospasm in conditions such as asthma and COPD. It works by relaxing the muscles around the airways, making it easier to breathe."

A Metered Dose Inhaler (MDI) is a medical device used to administer a specific amount or "metered dose" of medication, usually in the form of an aerosol, directly into the lungs of a patient. The MDI consists of a pressurized canister that contains the medication mixed with a propellant, a metering valve that releases a precise quantity of the medication, and a mouthpiece or mask for the patient to inhale the medication.

MDIs are commonly used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. They are also used to deliver other medications such as corticosteroids, anticholinergics, and beta-agonists. Proper use of an MDI requires coordination between the pressing of the canister and inhalation of the medication, which may be challenging for some patients. Therefore, it is essential to receive proper training on how to use an MDI effectively.

Bronchodilators are medications that relax and widen the airways (bronchioles) in the lungs, making it easier to breathe. They work by relaxing the smooth muscle around the airways, which allows them to dilate or open up. This results in improved airflow and reduced symptoms of bronchoconstriction, such as wheezing, coughing, and shortness of breath.

Bronchodilators can be classified into two main types: short-acting and long-acting. Short-acting bronchodilators are used for quick relief of symptoms and last for 4 to 6 hours, while long-acting bronchodilators are used for maintenance therapy and provide symptom relief for 12 hours or more.

Examples of bronchodilator agents include:

* Short-acting beta-agonists (SABAs) such as albuterol, levalbuterol, and pirbuterol
* Long-acting beta-agonists (LABAs) such as salmeterol, formoterol, and indacaterol
* Anticholinergics such as ipratropium, tiotropium, and aclidinium
* Combination bronchodilators that contain both a LABA and an anticholinergic, such as umeclidinium/vilanterol and glycopyrrolate/formoterol.

Adrenergic beta-agonists are a class of medications that bind to and activate beta-adrenergic receptors, which are found in various tissues throughout the body. These receptors are part of the sympathetic nervous system and mediate the effects of the neurotransmitter norepinephrine (also called noradrenaline) and the hormone epinephrine (also called adrenaline).

When beta-agonists bind to these receptors, they stimulate a range of physiological responses, including relaxation of smooth muscle in the airways, increased heart rate and contractility, and increased metabolic rate. As a result, adrenergic beta-agonists are often used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis, as they can help to dilate the airways and improve breathing.

There are several different types of beta-agonists, including short-acting and long-acting formulations. Short-acting beta-agonists (SABAs) are typically used for quick relief of symptoms, while long-acting beta-agonists (LABAs) are used for more sustained symptom control. Examples of adrenergic beta-agonists include albuterol (also known as salbutamol), terbutaline, formoterol, and salmeterol.

It's worth noting that while adrenergic beta-agonists can be very effective in treating respiratory conditions, they can also have side effects, particularly if used in high doses or for prolonged periods of time. These may include tremors, anxiety, palpitations, and increased blood pressure. As with any medication, it's important to use adrenergic beta-agonists only as directed by a healthcare professional.

No FAQ available that match "levalbuterol"

No images available that match "levalbuterol"